{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:32:46Z","timestamp":1747153966096,"version":"3.40.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Surg Oncol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s13193-020-01245-w","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T05:02:39Z","timestamp":1602824559000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Expression of PDL1 and Her2neu in Gastric and Gastroesophageal Junction Adenocarcinoma"],"prefix":"10.1007","volume":"12","author":[{"given":"Animesh","family":"Saurabh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1422-2240","authenticated-orcid":false,"given":"Vandana","family":"Raphael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biswajit","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Jagtap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"1245_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108","journal-title":"CA Cancer J Clin"},{"key":"1245_CR2","first-page":"15","volume":"7","author":"Z Sanaat","year":"2013","unstructured":"Sanaat Z, Halimi M, Ghojezadeh M, Pirovi AH, Gharamaleki JV, Ziae AE, Kermani IA (2013) Immunohistochemical analysis of p53, ki67, CD44, Her2\/neu expression pattern in gastric cancer, and their association with one-year survival in north-west of Iran. Int J Hematol Oncol Stem Cell Res 7:15\u201320","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"1245_CR3","doi-asserted-by":"publisher","first-page":"e0182692","DOI":"10.1371\/journal.pone.0182692","volume":"12","author":"L Gu","year":"2017","unstructured":"Gu L, Chen M, Guo D, Zhu H, Zhang W, Pan J, Zhong X, Li X, Qian H, Wang X (2017) PDL1 and gastric cancer prognosis: a systematic review and meta-analysis. PLoS One 12:e0182692","journal-title":"PLoS One"},{"key":"1245_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1746-1596-8-76","volume":"8","author":"L Shan","year":"2013","unstructured":"Shan L, Ying J, Lu N (2013) Her2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population. Diagn Pathol 8:76","journal-title":"Diagn Pathol"},{"key":"1245_CR5","first-page":"1989","volume":"11","author":"P Wei","year":"2018","unstructured":"Wei P, Jin M, Zhou X, Hu X, Wang Y (2018) Programmed death-1 and PD-1 ligand-1 expression in early onset gastric carcinoma and correlation with clinicopathological characteristics. Int J Clin Exp Pathol 11:1989\u20131998","journal-title":"Int J Clin Exp Pathol"},{"key":"1245_CR6","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.3748\/wjg.v22.i19.4619","volume":"22","author":"LF Abrahao-Machado","year":"2016","unstructured":"Abrahao-Machado LF, Scapulatempo-neto C (2016) HER2 testing in gastric cancer: an update. World J Gastroenterol 22:4619\u20134625","journal-title":"World J Gastroenterol"},{"key":"1245_CR7","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.17554\/j.issn.2224-3992.2017.06.707","volume":"6","author":"TH Sankalecha","year":"2017","unstructured":"Sankalecha TH, Gupta S, Gaikwad N, Ughade S (2017) Correlation of P53 expression with various clinicopathological parameters of gastric carcinoma and its relationship with survival. J Gastroenterol Hepatol Res 6:2370\u20132375","journal-title":"J Gastroenterol Hepatol Res"},{"key":"1245_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/PPO.0000000000000061","volume":"20","author":"MF Sanmamed","year":"2014","unstructured":"Sanmamed MF, Chen L (2014) Inducible expression of B7-H1 (PD-L1) and its selective role in tumor site immune modulation. Cancer J 20:256\u2013261","journal-title":"Cancer J"},{"key":"1245_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.7150\/jca.16239","volume":"8","author":"A Adamczyk","year":"2017","unstructured":"Adamczyk A, Grela-Wojewoda A, Domaga\u0142a-Haduch M, Ambicka A, Harazin-Lechowska A, Janecka A, Cedrych I, Majchrzyk K, Kruczak A, Ry\u015b J, Niemiec J (2017) Proteins involved in HER2 signalling pathway, their relations and influence on metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting. J Cancer 8:131\u2013139","journal-title":"J Cancer"},{"key":"1245_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4251\/wjgo.v7.i8.95","volume":"7","author":"d E Guillebon","year":"2015","unstructured":"Guillebon d E, Roussille P, Frouin E, Tougeron D (2015) Anti program death-1\/anti program death-ligand 1 in digestive cancers. World J Gastrointest Oncol 7:95\u2013101","journal-title":"World J Gastrointest Oncol"},{"key":"1245_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.acthis.2006.01.003","volume":"108","author":"C Wu","year":"2006","unstructured":"Wu C, Zhu Y, Jiang J, Zhao J, Zhang XG, Xu N (2006) Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. Acta Histochem 108:19\u201324","journal-title":"Acta Histochem"},{"key":"1245_CR12","first-page":"5369","volume":"35","author":"T Tamura","year":"2015","unstructured":"Tamura T, Ohira M, Tanaka H (2015) Programmed death-1 ligand-1 (PDL1) expression is associated with the prognosis of patients with stage II\/III gastric cancer. Anticancer Res 35:5369\u20135376","journal-title":"Anticancer Res"},{"key":"1245_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1462-5822.2008.01269.x","volume":"11","author":"N Tegtmeyer","year":"2009","unstructured":"Tegtmeyer N, Zabler D, Schmidt D, Hartig R, Brandt S, Backert S (2009) Importance of EGF receptor, HER2\/Neu and Erk1\/2 kinase signalling for host cell elongation and scattering induced by the Helicobacter pylori CagA protein: antagonistic effects of the vacuolating cytotoxin VacA. Cell Microbiol 11:488\u2013505","journal-title":"Cell Microbiol"},{"key":"1245_CR14","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1126\/science.3012781","volume":"232","author":"T Akiyama","year":"1986","unstructured":"Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T (1986) The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232:1644\u20131641","journal-title":"Science"},{"key":"1245_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235:177\u2013182","journal-title":"Science"},{"key":"1245_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10555-015-9552-6","volume":"34","author":"M Yan","year":"2015","unstructured":"Yan M, Schwaederle M, Arguello D, Millis SZ, Gatalica Z, Kurzrock R (2015) HER2 expression status in diverse cancers: review of results from 37,992 patients. Cancer Metastasis Rev 34:157\u2013164","journal-title":"Cancer Metastasis Rev"},{"key":"1245_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"DJ Slamon","year":"1989","unstructured":"Slamon DJ, Godolphin W, Jones LA, Holt J, Wong S, Keith D, Levin W, Stuart S, Udove J, Ullrich A et al (1989) Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science 244:707\u2013712","journal-title":"Science"},{"key":"1245_CR18","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1200\/jco.2009.27.15_suppl.4556","volume":"27","author":"Y Bang","year":"2009","unstructured":"Bang Y, Chung H, Xu J et al (2009) Pathological features of advanced gastric cancer (GC): relationship to human epidermal growth factor receptor-2 (Her2) positivity in the global screening programme of the ToGA trial. J Clin Oncol 27:4556","journal-title":"J Clin Oncol"},{"key":"1245_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1245\/s10434-012-2818-0","volume":"20","author":"J Cho","year":"2012","unstructured":"Cho J, Jeong J, Sung J et al (2012) A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages. Ann Surg Oncol 20:477\u2013484","journal-title":"Ann Surg Oncol"},{"key":"1245_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12876-015-0384-1","volume":"15","author":"RS Laboissiere","year":"2015","unstructured":"Laboissiere RS, Buzelin MA, Balabram D et al (2015) Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections. BMC Gastroenterol 15:157","journal-title":"BMC Gastroenterol"},{"key":"1245_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41392-018-0022-9","volume":"3","author":"D Escor","year":"2018","unstructured":"Escor D, Gato-Ca\u00f1as M, Zuazo M et al (2018) The intracellular signalosome of PD-L1 in cancer cells. Signal Transduct Target Ther 3:26","journal-title":"Signal Transduct Target Ther"},{"key":"1245_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10120-016-0631-3","volume":"20","author":"A Kawazoe","year":"2017","unstructured":"Kawazoe A, Kuwata T, Kuboki Y, Shitara K, Nagatsuma AK, Aizawa M, Yoshino T, Doi T, Ohtsu A, Ochiai A (2017) Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients. Gastric Cancer 20:407\u2013415","journal-title":"Gastric Cancer"},{"key":"1245_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7150\/jca.4090","volume":"3","author":"JT J\u00f8rgensen","year":"2012","unstructured":"J\u00f8rgensen JT, Hersom M (2012) HER2 as a prognostic marker in gastric cancer - a systematic analysis of data from the literature. J Cancer 3:137\u2013144","journal-title":"J Cancer"}],"container-title":["Indian Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-020-01245-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13193-020-01245-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-020-01245-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T21:07:27Z","timestamp":1634418447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13193-020-01245-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":23,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1007\/s13193-020-01245-w","relation":{},"ISSN":["0975-7651","0976-6952"],"issn-type":[{"type":"print","value":"0975-7651"},{"type":"electronic","value":"0976-6952"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"assertion":[{"value":"4 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by Institute Research and Ethics Committee (NEIGR\/IEC\/M3\/T9\/17).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Consent to participate and publish the patient\u2019s data was received from the patient and retained by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate and Publish"}}]}}